Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in Black Patients with SLE
NCT01632241Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2013
- Primary completion
- Jun 2018
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 4 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by GSK. Started Feb 2013; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01632241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01632241.